EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,128,000 | -26.8% | 36,326 | -3.3% | 0.02% | -13.6% |
| Q1 2022 | $1,542,000 | +6.4% | 37,564 | +12.7% | 0.02% | +15.8% |
| Q4 2021 | $1,449,000 | -21.4% | 33,338 | -9.5% | 0.02% | -26.9% |
| Q3 2021 | $1,844,000 | -20.1% | 36,832 | +0.5% | 0.03% | -21.2% |
| Q2 2021 | $2,309,000 | -7.2% | 36,664 | +36.9% | 0.03% | -15.4% |
| Q1 2021 | $2,487,000 | +13.1% | 26,773 | +9.1% | 0.04% | +5.4% |
| Q4 2020 | $2,198,000 | -13.2% | 24,536 | +0.1% | 0.04% | -24.5% |
| Q3 2020 | $2,532,000 | -31.9% | 24,508 | -47.9% | 0.05% | -36.4% |
| Q2 2020 | $3,717,000 | +59.0% | 47,014 | +16.3% | 0.08% | +35.1% |
| Q1 2020 | $2,338,000 | +21.2% | 40,408 | +13.0% | 0.06% | +39.0% |
| Q4 2019 | $1,929,000 | +2.4% | 35,762 | -0.8% | 0.04% | -2.4% |
| Q3 2019 | $1,884,000 | +6.2% | 36,036 | -1.8% | 0.04% | +7.7% |
| Q2 2019 | $1,774,000 | – | 36,713 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIMZ Investment Advisors, LLC | 52,590 | $621 | 0.29% |
| Values First Advisors, Inc. | 33,942 | $400,858 | 0.28% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 91,000 | $1,075,000 | 0.23% |
| SummerHaven Investment Management, LLC | 25,347 | $299,348 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 501,672 | $5,924,746 | 0.16% |
| CORNERCAP INVESTMENT COUNSEL INC | 67,457 | $796,667 | 0.14% |
| Edgestream Partners, L.P. | 94,553 | $1,116,671 | 0.13% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,569 | $1,022,380 | 0.12% |
| DUALITY ADVISERS, LP | 77,298 | $912,889 | 0.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,253,042 | $14,798,427 | 0.10% |